[HTML][HTML] 每日热点网-国际综合资讯平台admin 2021-04-14 11: 07
GBW DARMSTADT - clinical study, 2021 - mrrdw.com
… relapsed small cell lung cancer (SCLC), including durable responses … showed higher than
expected response rates and durable … Most patients (68.0%) experienced tumor regressions. …
expected response rates and durable … Most patients (68.0%) experienced tumor regressions. …
[HTML][HTML] 中国人物访谈网admin 2021-04-14 11: 07
GBW DARMSTADT - clinical study, 2021 - chinayskt.com
… relapsed small cell lung cancer (SCLC), including durable responses … showed higher than
expected response rates and durable … Most patients (68.0%) experienced tumor regressions. …
expected response rates and durable … Most patients (68.0%) experienced tumor regressions. …
ATR 抑制剂抗肿瘤治疗的研究新进展
刘竹君， 刘东颖 - 中国肿瘤临床, 2023 - cjco.cn
… ATR inhibitors for anticancer therapy, as single agents and in combination with chemotherapy,
radiation therapy, and novel targeted … 细胞 肺癌(non-small cell lung cancer,NSCLC)和头颈…
radiation therapy, and novel targeted … 细胞 肺癌(non-small cell lung cancer,NSCLC)和头颈…
神经内分泌肿瘤药物临床试验进展
梁贇， 吉顺荣， 虞先濬， 陈洁 - 中国癌症杂志, 2022 - china-oncology.com
… Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with
high replication stress[J]. Cancer Cell, 2021, 39(4): 566-579.e7. …
high replication stress[J]. Cancer Cell, 2021, 39(4): 566-579.e7. …